| A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects (NCT07560033) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2026-04-20 |
| A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis (NCT07420257) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2026-02-28 |
| The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity (NCT06830343) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2025-02-27 |
| Semaglutide in Treatment of Obesity (NCT06604624) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2024-09-20 |
| A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus (NCT06258148) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2024-04-15 |
| A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus (NCT06235086) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2024-04-08 |
| A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity (NCT06226090) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2024-02-21 |
| A Study of TG103 Injection in Type 2 Diabetes Subjects (NCT05348122) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2022-06-15 |
| A Study of TG103 Injection in Overweight or Obesity (NCT05299697) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2022-05-20 |
| A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes (NCT05063253) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2021-10-01 |
| Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refractory Chronic Spontaneous Urticaria (NCT04944602) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2021-07-01 |
| A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes (NCT04855292) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2021-07-01 |
| A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects (NCT04839744) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2021-05-18 |
| Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies (NCT04497701) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2020-08-01 |
| Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome (NCT04500886) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2020-08-01 |
| Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer (NCT04239001) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2020-02-01 |
| Evaluation of the Application of PEGylated Recombinant Human Granulocyte Stimulating Factor Injection (PEG-rhG-CSF) in Chemotherapy of Elderly Lymphoma Patients (NCT03870412) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2019-02-22 |
| Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia (NCT03846414) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2019-02-13 |
| Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma (NCT04497688) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2019-01-01 |
| PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy (NCT03776604) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2018-12-05 |